NO20033683D0 - 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer - Google Patents

2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer

Info

Publication number
NO20033683D0
NO20033683D0 NO20033683A NO20033683A NO20033683D0 NO 20033683 D0 NO20033683 D0 NO 20033683D0 NO 20033683 A NO20033683 A NO 20033683A NO 20033683 A NO20033683 A NO 20033683A NO 20033683 D0 NO20033683 D0 NO 20033683D0
Authority
NO
Norway
Prior art keywords
potassium channel
channel modulators
carboxamide derivatives
kcnq potassium
disubstituted pyrimidine
Prior art date
Application number
NO20033683A
Other languages
English (en)
Other versions
NO20033683L (no
Inventor
Piyasena Hewawasam
Dharmpal S Dodd
Charles D Weaver
Pierre Dextraze
Valentin K Gribkoff
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20033683D0 publication Critical patent/NO20033683D0/no
Publication of NO20033683L publication Critical patent/NO20033683L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
NO20033683A 2001-02-20 2003-08-19 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer NO20033683L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26980001P 2001-02-20 2001-02-20
PCT/US2002/004305 WO2002066036A1 (en) 2001-02-20 2002-02-14 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators

Publications (2)

Publication Number Publication Date
NO20033683D0 true NO20033683D0 (no) 2003-08-19
NO20033683L NO20033683L (no) 2003-10-17

Family

ID=23028698

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033683A NO20033683L (no) 2001-02-20 2003-08-19 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer

Country Status (10)

Country Link
US (1) US20020183335A1 (no)
EP (1) EP1361879A1 (no)
JP (1) JP2005508833A (no)
CA (1) CA2438231A1 (no)
CZ (1) CZ20032233A3 (no)
HU (1) HUP0303841A2 (no)
MX (1) MXPA03007395A (no)
NO (1) NO20033683L (no)
PL (1) PL372944A1 (no)
WO (1) WO2002066036A1 (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2463989C (en) * 2001-10-17 2012-01-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
EP1453516A2 (de) 2001-10-17 2004-09-08 Boehringer Ingelheim Pharma GmbH & Co.KG 5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
US7205307B2 (en) 2002-02-14 2007-04-17 Icagen, Inc. Pyrimidines as novel openers of potassium ion channels
US7176310B1 (en) * 2002-04-09 2007-02-13 Ucb Sa Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
ES2273077T3 (es) * 2002-08-21 2007-05-01 Glaxo Group Limited Derivados de 2-fenilamino-4-trifluorometil-5 (bencil- o piridin-4-il-metil) carbamoilpirimidina como moduladores selectivos del receptor cannabinoide cb2.
UY27939A1 (es) 2002-08-21 2004-03-31 Glaxo Group Ltd Compuestos
US7459460B2 (en) * 2003-05-28 2008-12-02 Bristol-Myers Squibb Company Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
PE20051029A1 (es) * 2003-07-02 2005-12-07 Vertex Pharma Pirimidinas moduladoras de canales ionicos regulados por voltaje
MXPA06006120A (es) * 2003-12-01 2007-04-16 Kudos Pharm Ltd Inhibidores de reparacion de dano de acido desoxirribonucleico para tratamiento de cancer.
GB0402356D0 (en) * 2004-02-03 2004-03-10 Glaxo Group Ltd Novel compounds
GB0404105D0 (en) * 2004-02-24 2004-03-31 Glaxo Group Ltd Novel compounds
TWI357901B (en) 2004-03-12 2012-02-11 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivati
AU2005232745A1 (en) 2004-04-13 2005-10-27 Astellas Pharma Inc. Polycyclic pyrimidines as potassium ion channel modulators
WO2006047504A1 (en) * 2004-10-22 2006-05-04 Janssen Pharmaceutica, N.V. Aromatic amides as inhibitors of c-fms kinase
US7767680B2 (en) 2004-11-03 2010-08-03 Vertex Pharmaceuticals Incorporated Ion channel modulators and methods of use
UA92340C2 (en) * 2005-03-03 2010-10-25 Х. Луннбек А/С Substituted pyridine derivatives
US7812020B2 (en) * 2005-03-03 2010-10-12 H. Lundbeck A/S Substituted pyridine derivatives
EP1863796A1 (en) * 2005-03-22 2007-12-12 NeuroSearch A/S Pyrazolyl-pyrimidines as potassium channel modulating agents and their medical use
DE102005038947A1 (de) 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
EP1904491A2 (en) * 2005-05-31 2008-04-02 Vertex Pharmaceuticals Incorporated Heterocycles useful as modulators of ion channels
US7683058B2 (en) 2005-09-09 2010-03-23 H. Lundbeck A/S Substituted pyrimidine derivatives
BRPI0615631A2 (pt) * 2005-09-09 2011-05-24 Lundbeck & Co As H composto, composição farmacêutica, e, uso de uma composição farmacêutica
CA2679198C (en) 2007-02-26 2011-07-12 Pfizer Products Inc. Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
MX2010010209A (es) 2008-03-18 2010-10-05 Merck Sharp & Dohme 4-hidroxipirimidina-5-carboxamidas sustituidas.
TWI504395B (zh) 2009-03-10 2015-10-21 Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier
TWI475020B (zh) * 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
TWI461197B (zh) 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
CA2804165C (en) * 2010-07-08 2015-02-24 Pfizer Inc. Piperidinyl pyrimidine amides as kv7 potassium channel openers
BR112013004690A2 (pt) 2010-08-27 2016-05-10 Gruenenthal Gmbh 2-oxo-e 2-tioxo-di-hidroquinolina-3-carboxamidas substituídas como moduladores kcnq2/3
US8653101B2 (en) 2010-08-27 2014-02-18 Gruenenthal Gmbh Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
US8470852B2 (en) 2010-08-27 2013-06-25 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
CA2807886A1 (en) 2010-09-01 2012-03-08 Gruenenthal Gmbh Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
US9168259B2 (en) 2010-10-20 2015-10-27 Grünenthal GmbH Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
PE20140199A1 (es) 2010-10-20 2014-02-16 Gruenenthal Chemie 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3
MX2014012491A (es) 2012-04-18 2014-11-14 Grünenthal GmbH 4-aminobenzamidas sustituidas como moduladores de kcnq2/3.
CA2870573A1 (en) 2012-04-18 2013-10-24 Grunenthal Gmbh Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators
BR112015012418A2 (pt) 2012-11-28 2017-07-11 Gruenenthal Gmbh carboxamidas específicas como moduladores de kcnq2/3
US9248122B2 (en) 2012-11-28 2016-02-02 Grünenthal GmbH Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
MX2015006688A (es) * 2012-11-28 2015-08-10 Grünenthal GmbH Amino-arilcarboxamidas sustituidas como moduladores de kcnq2/3.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852028A (en) * 1995-12-18 1998-12-22 Signal Pharmaceuticals, Inc. Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
US5811428A (en) * 1995-12-18 1998-09-22 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
US5935966A (en) * 1995-09-01 1999-08-10 Signal Pharmaceuticals, Inc. Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
TW550258B (en) * 1999-05-31 2003-09-01 Hoffmann La Roche 4-phenyl-pyrimidine derivatives
CA2378243C (en) * 1999-08-04 2012-05-15 Icagen, Inc. Methods for treating or preventing pain and anxiety
IL157313A0 (en) * 2001-02-20 2004-02-19 Bristol Myers Squibb Co Modulators of kcnq potassium channels and uses thereof

Also Published As

Publication number Publication date
PL372944A1 (en) 2005-08-08
HUP0303841A2 (hu) 2004-03-01
JP2005508833A (ja) 2005-04-07
NO20033683L (no) 2003-10-17
CA2438231A1 (en) 2002-08-29
MXPA03007395A (es) 2003-12-04
EP1361879A1 (en) 2003-11-19
CZ20032233A3 (cs) 2004-12-15
US20020183335A1 (en) 2002-12-05
WO2002066036A1 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
NO20033683D0 (no) 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer
NO20012739D0 (no) 3-substituerte-4-arylquinolin-2-on-derivater som kaliumkanal modulatorer
DK1446394T3 (da) Hidtil ukendte 1,2,4-thiadiazolderivater som melanocortinreceptormodulatorer
DK1414803T3 (da) Pyrazolylcarboxanilider som fungicider
NO20035245L (no) Grunnleggende Wi-Fi-arkitektur for 802.11-nettverk
NO20052995D0 (no) 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer.
NO20034930L (no) Substituerte cykloheksan-1,4-diaminderivater
NO20022649D0 (no) Heterocykliske dihydropyrimidiner som kaliumkanal inhibitorer
NO20040632L (no) 2-amino-4,5-trisubstituerte tiazolylderivater.
DK1593670T3 (da) Hydroxysubstituerede 2-azetidinoner, der er anvendelige som hypokolesterolæmiske midler
NO20033353D0 (no) Karotenoid biosyntese
DK1429607T3 (da) Delta-1-pyrroliner som pesticider
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
NO20033234L (no) Karotenoider som antihypertensjonsmidler
NO20005570D0 (no) Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalÕpnere
NO20044413L (no) 1,2-Dihydropyrazol-3-oner som cytokinmediatorer
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
ITTO20020747A1 (it) Composizione.
DK1349850T3 (da) Natriumkanalmodulatorer, der er afledt af 2-piperidylimidazoler
ITMI20022183A1 (it) Cerniera.
DK1487802T3 (da) 2,3-diaryl-pyrazolidin-derivater som neurotensin-nedbrydende enzyminhibitorer
ITTO20020745A1 (it) Composizione.
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application